Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-20 7:10 pm Sale | 13D | Humacyte Inc. HUMA | Niklason Laura E | 6,007,745 4.600% | -1,697,728 (-22.03%) | View |
| 2024-11-18 4:10 pm Unchanged | 13D | Humacyte Inc. HUMA | FRESENIUS MEDICAL CARE HOLDINGS INC | 18,312,735 14.200% | 0 (Unchanged) | View |
| 2024-11-08 2:17 pm Unchanged | 13G | Humacyte Inc. HUMA | BlackRock Inc. | 7,539,339 6.300% | 0 (Unchanged) | View |
| 2024-10-24 2:02 pm Purchase | 13G | Humacyte Inc. HUMA | BlackRock Inc. | 7,539,339 6.300% | 7,539,339 (New Position) | View |
| 2024-09-03 4:11 pm Sale | 13D | Humacyte Inc. HUMA | Niklason Laura E | 7,705,473 6.300% | -1,481,428 (-16.13%) | View |
| 2024-06-04 7:00 pm Sale | 13D | Humacyte Inc. HUMA | Niklason Laura E | 9,186,901 7.600% | -966,294 (-9.52%) | View |
| 2024-03-08 4:03 pm Purchase | 13D | Humacyte Inc. HUMA | Niklason Laura E | 10,153,195 8.400% | 102,373 (+1.02%) | View |
| 2024-03-07 3:04 pm Purchase | 13D | Humacyte Inc. HUMA | FRESENIUS MEDICAL CARE HOLDINGS INC | 18,312,735 15.400% | 18,312,735 (New Position) | View |
| 2023-12-01 10:50 am Sale | 13D | Humacyte Inc. HUMA | FRESENIUS MEDICAL CARE HOLDINGS INC | 0 0.000% | -18,312,735 (Position Closed) | View |
| 2023-09-15 4:09 pm Sale | 13D | Humacyte Inc. HUMA | Niklason Laura E | 10,050,822 9.500% | -1,561,987 (-13.45%) | View |
| 2023-08-21 6:19 pm Sale | 13D | Humacyte Inc. HUMA | Niklason Laura E | 11,612,809 11.100% | -2,298,579 (-16.52%) | View |
| 2023-06-15 4:23 pm Sale | 13D | Humacyte Inc. HUMA | Niklason Laura E | 13,911,388 13.200% | -4,874,823 (-25.95%) | View |
| 2023-05-26 5:05 pm Sale | 13D | Humacyte Inc. HUMA | Niklason Laura E | 18,786,211 17.900% | -3,550,200 (-15.89%) | View |
| 2022-09-19 4:39 pm Sale | 13D | Humacyte Inc. HUMA | Niklason Laura E | 22,336,411 21.300% | -931,868 (-4.00%) | View |
| 2022-02-14 4:30 pm Sale | 13G | Humacyte Inc. HUMA | GLAZER CAPITAL LLC | 0 0.000% | -750,127 (Position Closed) | View |
| 2022-02-09 11:12 am Unchanged | 13G | Humacyte Inc. HUMA | Parian Global Management LP | 0 0.000% | 0 (Unchanged) | View |
| 2021-09-08 4:22 pm Purchase | 13G | Humacyte Inc. HUMA | PTC Trustees GY Ltd as Trustee of The GYF Trust | 8,942,078 8.700% | 8,942,078 (New Position) | View |
| 2021-09-02 06:04 am Purchase | 13D | Humacyte Inc. HUMA | FRESENIUS MEDICAL CARE HOLDINGS INC | 18,312,735 17.800% | 18,312,735 (New Position) | View |
| 2021-08-27 9:14 pm Purchase | 13D | Humacyte Inc. HUMA | Niklason Laura E | 23,268,279 22.400% | 23,268,279 (New Position) | View |
| 2021-03-01 4:33 pm Purchase | 13G | Humacyte Inc. HUMA | Parian Global Management LP | 844,734 8.160% | 844,734 (New Position) | View |